205 related articles for article (PubMed ID: 26197210)
1. Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies.
Tavitian S; Peron JM; Huguet F; Kamar N; Abravanel F; Beyne-Rauzy O; Oberic L; Faguer S; Alric L; Roussel M; Gaudin C; Ysebaert L; Huynh A; Recher C
Emerg Infect Dis; 2015 Aug; 21(8):1466-9. PubMed ID: 26197210
[TBL] [Abstract][Full Text] [Related]
2. The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study.
von Felden J; Alric L; Pischke S; Aitken C; Schlabe S; Spengler U; Giordani MT; Schnitzler P; Bettinger D; Thimme R; Xhaard A; Binder M; Ayuk F; Lohse AW; Cornelissen JJ; de Man RA; Mallet V
J Hepatol; 2019 Sep; 71(3):465-472. PubMed ID: 31108159
[TBL] [Abstract][Full Text] [Related]
3. Sofosbuvir shows antiviral activity in a patient with chronic hepatitis E virus infection.
van der Valk M; Zaaijer HL; Kater AP; Schinkel J
J Hepatol; 2017 Jan; 66(1):242-243. PubMed ID: 27702641
[No Abstract] [Full Text] [Related]
4. A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients.
Debing Y; Gisa A; Dallmeier K; Pischke S; Bremer B; Manns M; Wedemeyer H; Suneetha PV; Neyts J
Gastroenterology; 2014 Nov; 147(5):1008-11.e7; quiz e15-6. PubMed ID: 25181691
[TBL] [Abstract][Full Text] [Related]
5. Chronic Hepatitis E in a Renal Transplant Recipient: The First Report of Genotype 4 Hepatitis E Virus Caused Chronic Infection in Organ Recipient.
Wang Y; Chen G; Pan Q; Zhao J
Gastroenterology; 2018 Mar; 154(4):1199-1201. PubMed ID: 29432746
[No Abstract] [Full Text] [Related]
6. Hepatitis E virus treatment and ribavirin therapy: viral mechanisms of nonresponse.
Todt D; Meister TL; Steinmann E
Curr Opin Virol; 2018 Oct; 32():80-87. PubMed ID: 30384328
[TBL] [Abstract][Full Text] [Related]
7. [Chronic Hepatitis E Virus Infection and Treatment in Organ Transplant Recipients].
Chen S; Wei F; Wu T; Xia N
Bing Du Xue Bao; 2015 May; 31(3):293-8. PubMed ID: 26470537
[TBL] [Abstract][Full Text] [Related]
8. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin.
Lhomme S; DebRoy S; Kamar N; Abravanel F; Metsu D; Marion O; Dimeglio C; Cotler SJ; Izopet J; Dahari H
Viruses; 2019 Jul; 11(7):. PubMed ID: 31323954
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment.
Aslan AT; Balaban HY
World J Gastroenterol; 2020 Oct; 26(37):5543-5560. PubMed ID: 33071523
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hepatitis E virus.
Dalton HR; Kamar N
Curr Opin Infect Dis; 2016 Dec; 29(6):639-644. PubMed ID: 27607911
[TBL] [Abstract][Full Text] [Related]
11. Unmet Needs for the Treatment of Chronic Hepatitis E Virus Infection in Immunocompromised Patients.
Kamar N; Del Bello A; Abravanel F; Pan Q; Izopet J
Viruses; 2022 Sep; 14(10):. PubMed ID: 36298671
[TBL] [Abstract][Full Text] [Related]
12. Chronic Hepatitis E Viral Infection After Liver Transplantation: A Regression of Fibrosis After Antiviral Therapy.
Mazzola A; Tran Minh M; Charlotte F; Hdiji A; Bernard D; Wendum D; Calmus Y; Conti F
Transplantation; 2017 Sep; 101(9):2083-2087. PubMed ID: 28376032
[TBL] [Abstract][Full Text] [Related]
13. Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin.
Neukam K; Barreiro P; Macías J; Avellón A; Cifuentes C; Martín-Carbonero L; Echevarría JM; Vargas J; Soriano V; Pineda JA
Clin Infect Dis; 2013 Aug; 57(3):465-8. PubMed ID: 23575198
[TBL] [Abstract][Full Text] [Related]
14. [Chronic hepatitis caused by hepatitis E virus and treated with ribavirin].
Mora Soler AM; Velasco-Guardado A; Martín Arribas MI; Acosta Materan R; Revilla Morato C; Pérez Corte D; Rodríguez Pérez A
Gastroenterol Hepatol; 2016 Nov; 39(9):597-598. PubMed ID: 26589539
[No Abstract] [Full Text] [Related]
15. Successful Treatment of Chronic Hepatitis E After an Orthotopic Liver Transplant With Ribavirin Monotherapy.
Klein F; Neuhaus R; Hofmann J; Rudolph B; Neuhaus P; Bahra M
Exp Clin Transplant; 2015 Jun; 13(3):283-6. PubMed ID: 24779678
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and determinants of chronicity in hepatitis E virus infection.
Narayanan S; Abutaleb A; Sherman KE; Kottilil S
J Viral Hepat; 2019 Apr; 26(4):414-421. PubMed ID: 30636092
[TBL] [Abstract][Full Text] [Related]
17. Genotype 4 hepatitis E virus is a cause of chronic hepatitis in renal transplant recipients in Hong Kong.
Sridhar S; Chan JFW; Yap DYH; Teng JLL; Huang C; Yip CCY; Hung IFN; Tang SCW; Lau SKP; Woo PCY; Yuen KY
J Viral Hepat; 2018 Feb; 25(2):209-213. PubMed ID: 28984015
[No Abstract] [Full Text] [Related]
18. Sofosbuvir monotherapy fails to achieve HEV RNA elimination in patients with chronic hepatitis E - The HepNet SofE pilot study.
Cornberg M; Pischke S; Müller T; Behrendt P; Piecha F; Benckert J; Todt D; Steinmann E; Papkalla A; von Karpowitz M; Koch A; Lohse A; Hardtke S; Manns MP; Wedemeyer H
J Hepatol; 2020 Sep; 73(3):696-699. PubMed ID: 32624195
[No Abstract] [Full Text] [Related]
19. Protracted fecal shedding of HEV during ribavirin therapy predicts treatment relapse.
Abravanel F; Lhomme S; Rostaing L; Kamar N; Izopet J
Clin Infect Dis; 2015 Jan; 60(1):96-9. PubMed ID: 25249523
[TBL] [Abstract][Full Text] [Related]
20. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection.
Kamar N; Rostaing L; Abravanel F; Garrouste C; Lhomme S; Esposito L; Basse G; Cointault O; Ribes D; Nogier MB; Alric L; Peron JM; Izopet J
Gastroenterology; 2010 Nov; 139(5):1612-8. PubMed ID: 20708006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]